MoneyWorks4Me

Glenmark Pharmaceuticals informs about media release

23 Jan 2023 Evaluate

Glenmark Pharmaceuticals has informed that it attached media release titled ‘Glenmark launches AKYNZEO® I.V. in India – First Fixed I.V. Antiemetic Combination for the Prevention of Chemotherapyinduced Nausea and Vomiting’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..